Abvc Biopharma (ABVC) Operating Margin (2016 - 2025)
Historic Operating Margin for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to 146.79%.
- Abvc Biopharma's Operating Margin fell 691300.0% to 146.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 1121.22%, marking a year-over-year decrease of 2360400.0%. This contributed to the annual value of 923.34% for FY2024, which is 35159000.0% up from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's Operating Margin is 146.79%, which was down 691300.0% from 1773.38% recorded in Q2 2025.
- Abvc Biopharma's Operating Margin's 5-year high stood at 1773.38% during Q2 2025, with a 5-year trough of 235539.83% in Q1 2024.
- Over the past 5 years, Abvc Biopharma's median Operating Margin value was 1486.05% (recorded in 2023), while the average stood at 20336.2%.
- In the last 5 years, Abvc Biopharma's Operating Margin crashed by 2000000000bps in 2024 and then skyrocketed by 2000000000bps in 2025.
- Abvc Biopharma's Operating Margin (Quarter) stood at 1638.04% in 2021, then plummeted by -132bps to 531.92% in 2022, then tumbled by -4345bps to 23641.34% in 2023, then tumbled by -52bps to 35837.44% in 2024, then skyrocketed by 100bps to 146.79% in 2025.
- Its Operating Margin was 146.79% in Q3 2025, compared to 1773.38% in Q2 2025 and 294.95% in Q1 2025.